review · Obesity Surgery
The growing frequency of bariatric surgeries has led to an increase in incidental medical findings during operative procedures. Among these, incidental gastric gastrointestinal stromal tumours appear in approximately 0.7 percent of operations. By combining clinical data from a single team with a systematic review of the broader literature, an approach was established to assess treatment options for these unexpected tumours. This effort seeks to optimise patient outcomes while reducing overall cancer risks. Additionally, a new classification framework for bariatric surgeries is introduced to account for newer operative techniques and to improve the clarity and execution of the proposed management strategies when these tumours are encountered.
When surgeons encounter unexpected tumours during routine weight-loss operations, they need clear strategies on how to proceed. Establishing standard ways to categorise surgeries and treat these growths helps healthcare teams make safer operative decisions, balancing the goals of the planned bariatric intervention with the immediate need to address potential cancer risks.
This work primarily informs clinical guidelines and decision-making protocols for bariatric and oncological surgeons. It represents applied conceptual research that can be utilised directly in operating theatres and hospital pathways, though the abstract does not indicate any direct product, device, or commercial development pathway.
AI-generated from the published abstract. Always read the original work before citing.
As bariatric surgeries (BS) increase, more incidental findings are liable to be discovered. Incidental gastric gastrointestinal stromal tumors (GISTs) during BS can be found in around 0.7% of the cases. In this article, we have performed a systematic review of the literature and added our data to those of the review to review a conceptual treatment strategy to both improve patient outcomes and decrease the risk of overall cancer. With the rise of new bariatric techniques, we have proposed a new classification to BS to enhance our description of the treatment strategy.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s11695-024-07224-2
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
